Skip to main content
Top
Published in: Journal of Gastrointestinal Cancer 2/2010

01-06-2010 | ORIGINAL RESEARCH

The Baseline Ratio of Neutrophils to Lymphocytes is Associated with Patient Prognosis in Rectal Carcinoma

Authors: Huanran Liu, Ge Liu, Quan Bao, Wei Sun, Haidong Bao, Liang Bi, Wei Wen, Yanfeng Liu, Zhenglin Wang, Xunguo Yin, Yunqing Bai, Xiang Hu

Published in: Journal of Gastrointestinal Cancer | Issue 2/2010

Login to get access

Abstract

Objective

In cancer patients, the balance between neutrophil (N) and lymphocyte (L) cell counts fluctuates with advancing disease. The objective of our study was to determine the prognostic implications of the N/L ratio in the peripheral blood of rectal cancer patients.

Methods

Study participants were identified from a prospective cohort of patients with rectal cancer in Dalian of China (n = 123).

Results

The median baseline N/L ratio was 2.41 ± 2.206 (range, 0.76–20.45). Our results revealed that the N/L ratio was significantly associated with tumor size (P = 0.003) and level of cancer antigen 125 (P = 0.027). A multivariate Cox model established a significant relationship between the N/L ratio and survival (adjusted hazard ratio, 2.615; 95% confidence interval, 1.152–5.933; P = 0.021).

Conclusions

These results suggest that the N/L ratio is an independent prognostic factor in rectal cancer, and the N/L ratio may serve as a clinically accessible and useful biomarker for patient survival.
Literature
1.
go back to reference Aaltomaa S, Lipponen P, Eskelinen M, et al. Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur J Cancer. 1992;28:859–64.CrossRef Aaltomaa S, Lipponen P, Eskelinen M, et al. Lymphocyte infiltrates as a prognostic variable in female breast cancer. Eur J Cancer. 1992;28:859–64.CrossRef
2.
go back to reference Kawata A, Une Y, Hosokawa M, et al. Tumor-infiltrating lymphocytes and prognosis of hepatocellular carcinoma. Jpn J Clin Oncol. 1992;22:256–63.PubMed Kawata A, Une Y, Hosokawa M, et al. Tumor-infiltrating lymphocytes and prognosis of hepatocellular carcinoma. Jpn J Clin Oncol. 1992;22:256–63.PubMed
3.
go back to reference Slootweg PJ, De Pagter M, De Weger RA, et al. Lymphocytes at tumor margins in patients with head and neck cancer. Relationship with tumor size, human lymphocyte antigen molecules, and metastasis. Int J Oral Maxillofac Surg. 1994;23:286–9.CrossRefPubMed Slootweg PJ, De Pagter M, De Weger RA, et al. Lymphocytes at tumor margins in patients with head and neck cancer. Relationship with tumor size, human lymphocyte antigen molecules, and metastasis. Int J Oral Maxillofac Surg. 1994;23:286–9.CrossRefPubMed
5.
go back to reference Petrie HT, Klassen LW, Kay HD, et al. Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol. 1985;134:230–4.PubMed Petrie HT, Klassen LW, Kay HD, et al. Inhibition of human cytotoxic T lymphocyte activity in vitro by autologous peripheral blood granulocytes. J Immunol. 1985;134:230–4.PubMed
6.
go back to reference El-Hag A, Clark RA. Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system. J Immunol. 1987;139:2406–13.PubMed El-Hag A, Clark RA. Immunosuppression by activated human neutrophils. Dependence on the myeloperoxidase system. J Immunol. 1987;139:2406–13.PubMed
7.
go back to reference Satomi A, Murakami S, Ishida K, et al. Significance of increased neutrophils in patients with advanced colorectal cancer. Acta Oncol. 1995;34:69–73.CrossRefPubMed Satomi A, Murakami S, Ishida K, et al. Significance of increased neutrophils in patients with advanced colorectal cancer. Acta Oncol. 1995;34:69–73.CrossRefPubMed
8.
go back to reference Walsh SR, Cook EJ, Goulder F, et al. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91:181–4.CrossRefPubMed Walsh SR, Cook EJ, Goulder F, et al. Neutrophil-lymphocyte ratio as a prognostic factor in colorectal cancer. J Surg Oncol. 2005;91:181–4.CrossRefPubMed
9.
go back to reference Liu H, Tabuchi T, Takemura A, et al. The granulocyte/lymphocyte ratio as an independent predictor of tumor growth, metastasis and progression: its clinical applications. Mol Med Rep. 2008;1:699–704. Liu H, Tabuchi T, Takemura A, et al. The granulocyte/lymphocyte ratio as an independent predictor of tumor growth, metastasis and progression: its clinical applications. Mol Med Rep. 2008;1:699–704.
10.
go back to reference Yamanaka T, Matsumoto S, Teramukai S, et al. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology. 2007;73:215–20.CrossRefPubMed Yamanaka T, Matsumoto S, Teramukai S, et al. The baseline ratio of neutrophils to lymphocytes is associated with patient prognosis in advanced gastric cancer. Oncology. 2007;73:215–20.CrossRefPubMed
11.
go back to reference Ietomi K. A study on the role of granulocytes in carcinoma-bearing hosts—G/L ratio as a new host indicator. Nippon Gan Chiryo Gakkai Shi. 1990;25:662–71.PubMed Ietomi K. A study on the role of granulocytes in carcinoma-bearing hosts—G/L ratio as a new host indicator. Nippon Gan Chiryo Gakkai Shi. 1990;25:662–71.PubMed
12.
go back to reference Hirashima M, Higuchi S, Sakamoto K, et al. The ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patients with early gastric cancer. J Cancer Res Clin Oncol. 1998;24:329–34.CrossRef Hirashima M, Higuchi S, Sakamoto K, et al. The ratio of neutrophils to lymphocytes and the phenotypes of neutrophils in patients with early gastric cancer. J Cancer Res Clin Oncol. 1998;24:329–34.CrossRef
13.
go back to reference Riesco A. Five-year cancer cure: relation to total amount of peripheral lymphocytes and neutrophils. Cancer. 1970;25:135–40.CrossRefPubMed Riesco A. Five-year cancer cure: relation to total amount of peripheral lymphocytes and neutrophils. Cancer. 1970;25:135–40.CrossRefPubMed
14.
go back to reference Atzpodien J, Royston P, Wandert T, et al. Metastatic renal carcinoma comprehensive prognostic system. Br J Cancer. 2003;88:348–53.CrossRefPubMed Atzpodien J, Royston P, Wandert T, et al. Metastatic renal carcinoma comprehensive prognostic system. Br J Cancer. 2003;88:348–53.CrossRefPubMed
15.
go back to reference Négrier S, Escudier B, Gomez F, et al. Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d'Immunothérapie. Ann Oncol. 2002;13:1460–8.CrossRefPubMed Négrier S, Escudier B, Gomez F, et al. Prognostic factors of survival and rapid progression in 782 patients with metastatic renal carcinomas treated by cytokines: a report from the Groupe Francais d'Immunothérapie. Ann Oncol. 2002;13:1460–8.CrossRefPubMed
16.
go back to reference Donskov F, von der Maase H. Impact of immune parameters on long-term survival in metastatic renal cell carcinoma. J Clin Oncol. 2006;24:1997–2005.CrossRefPubMed Donskov F, von der Maase H. Impact of immune parameters on long-term survival in metastatic renal cell carcinoma. J Clin Oncol. 2006;24:1997–2005.CrossRefPubMed
17.
go back to reference Schmidt H, Suciu S, Punt CJ, et al. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial. J Clin Oncol. 2007;25:1562–9.CrossRefPubMed Schmidt H, Suciu S, Punt CJ, et al. Pretreatment levels of peripheral neutrophils and leukocytes as independent predictors of overall survival in patients with American Joint Committee on Cancer Stage IV Melanoma: results of the EORTC 18951 Biochemotherapy Trial. J Clin Oncol. 2007;25:1562–9.CrossRefPubMed
18.
go back to reference Suzuki S, Toyabe S, Moroda T, et al. Circadian rhythm of leucocytes and lymphocytes subsets and its possible correlation with the function of the autonomic nervous system. Clin Exp Immunol. 1997;10:500–8.CrossRef Suzuki S, Toyabe S, Moroda T, et al. Circadian rhythm of leucocytes and lymphocytes subsets and its possible correlation with the function of the autonomic nervous system. Clin Exp Immunol. 1997;10:500–8.CrossRef
19.
go back to reference Ubukata H, Tabuchi T, Soma T, et al. The role of granulocyte in the immune response network against cancer. Biotherapy. 1992;6:776–8. Ubukata H, Tabuchi T, Soma T, et al. The role of granulocyte in the immune response network against cancer. Biotherapy. 1992;6:776–8.
20.
go back to reference Shau HY, Kim A. Suppression of lymphokine-activated killer induction by neutrophils. J Immunol. 1988;141:4395–402.PubMed Shau HY, Kim A. Suppression of lymphokine-activated killer induction by neutrophils. J Immunol. 1988;141:4395–402.PubMed
21.
go back to reference Rabinowich H, Cohen R, Bruderman I, et al. Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes. Cancer Res. 1987;47:173–7.PubMed Rabinowich H, Cohen R, Bruderman I, et al. Functional analysis of mononuclear cells infiltrating into tumors: lysis of autologous human tumor cells by cultured infiltrating lymphocytes. Cancer Res. 1987;47:173–7.PubMed
22.
23.
go back to reference Liu H, Ubukata H, Tabuchi T, et al. It is possible that tumor-infiltrating granulocytes promote tumor progression. Oncol Rep. 2009;22:29–33.PubMed Liu H, Ubukata H, Tabuchi T, et al. It is possible that tumor-infiltrating granulocytes promote tumor progression. Oncol Rep. 2009;22:29–33.PubMed
24.
go back to reference Di Carlo E, Forni G, Musiani P. Neutrophils in the antitumoral immune response. Chem Immunol Allergy. 2003;83:182–203.CrossRefPubMed Di Carlo E, Forni G, Musiani P. Neutrophils in the antitumoral immune response. Chem Immunol Allergy. 2003;83:182–203.CrossRefPubMed
25.
go back to reference Schaider H, Oka M, Bogenrieder T, et al. Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8. Int J Cancer. 2003;103:335–43.CrossRefPubMed Schaider H, Oka M, Bogenrieder T, et al. Differential response of primary and metastatic melanomas to neutrophils attracted by IL-8. Int J Cancer. 2003;103:335–43.CrossRefPubMed
26.
go back to reference Shamamian P, Schwartz JD, Pocock BJ, et al. Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J Cell Physiol. 2001;189:197–206.CrossRefPubMed Shamamian P, Schwartz JD, Pocock BJ, et al. Activation of progelatinase A (MMP-2) by neutrophil elastase, cathepsin G, and proteinase-3: a role for inflammatory cells in tumor invasion and angiogenesis. J Cell Physiol. 2001;189:197–206.CrossRefPubMed
27.
go back to reference Scapini P, Nesi L, Morini M, et al. Generation of biologically active angiostatin kringle 1–3 by activated human neutrophils. J Immunol. 2002;168:5798–804.PubMed Scapini P, Nesi L, Morini M, et al. Generation of biologically active angiostatin kringle 1–3 by activated human neutrophils. J Immunol. 2002;168:5798–804.PubMed
28.
go back to reference Kay HD, Smith DL. Regulation of human lymphocyte-mediated natural killer (NK) cell activity: inhibition in vitro by peripheral blood granulocytes. J Immunol. 1983;130:475–83.PubMed Kay HD, Smith DL. Regulation of human lymphocyte-mediated natural killer (NK) cell activity: inhibition in vitro by peripheral blood granulocytes. J Immunol. 1983;130:475–83.PubMed
29.
go back to reference Toge T, Yamaguchi Y. Protein-bound polysaccharide increases survival in resected gastric cancer cases stratified with a preoperative granulocyte and lymphocyte count. Oncol Rep. 2000;7:1157–61.PubMed Toge T, Yamaguchi Y. Protein-bound polysaccharide increases survival in resected gastric cancer cases stratified with a preoperative granulocyte and lymphocyte count. Oncol Rep. 2000;7:1157–61.PubMed
Metadata
Title
The Baseline Ratio of Neutrophils to Lymphocytes is Associated with Patient Prognosis in Rectal Carcinoma
Authors
Huanran Liu
Ge Liu
Quan Bao
Wei Sun
Haidong Bao
Liang Bi
Wei Wen
Yanfeng Liu
Zhenglin Wang
Xunguo Yin
Yunqing Bai
Xiang Hu
Publication date
01-06-2010
Publisher
Springer US
Published in
Journal of Gastrointestinal Cancer / Issue 2/2010
Print ISSN: 1941-6628
Electronic ISSN: 1941-6636
DOI
https://doi.org/10.1007/s12029-009-9125-4

Other articles of this Issue 2/2010

Journal of Gastrointestinal Cancer 2/2010 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.